IU Health Blood and Bone Marrow Stem Cell
Locations
Transplant Summary
Overview
The adult program is one of the leading centers for transplantation of patients with testicular/germ cell tumors. Clinical interests include immunotherapy and use of novel agents for treating patients with lymphoma and multiple myeloma. Research interests include haploidentical transplantation, adult cord blood transplantation, enhancement of post-transplant immune function, and graft vs host disease prevention and treatment. The pediatric program is the only stem cell transplant program in Indiana for children. Children treated include those with leukemia, solid tumors, immundeficiencies, sickle cell disease, other non-malignant conditions and rare genetic disorders. Research interests include graft vs. host disease and use of mesenchymal stromal cells for Fanconi Anemia. The Adult and Pediatric Programs are the first in Indiana to be certified to administer commercial CART-cell Therapy.This center has been performing allogeneic transplants since 1985 and has been an NMDP transplant center since January 1988.
Attending physicians
Adult - Rafat Abonour, Varun Mittal, Michael Robertson, Jennifer Schwartz
Pediatric - W. Scott Goebel, Mirian Kim, April Rahrig, Kent Robertson, Jodi SkilesTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricPatient survival information for this center
This center's actual 1-year survival results are below the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 224 patients.The actual 1-year survival of these patients is 72.3%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 74.6% and 84.6%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
524
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow1PBSC57Cord blood0Total58Unrelated donorMarrow4PBSC82Cord blood0Total86Total allogeneicMarrow5PBSC139Cord blood0Total144AutologousMarrowBoth marrow & PBSC 380PBSC—Cord blood—Total380Total combinedMarrowBoth marrow & PBSC 524PBSC—Cord blood0Total524Total pediatric transplants
69
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow18PBSC4Cord blood2Total24Unrelated donorMarrow5PBSC3Cord blood3Total11Total allogeneicMarrow23PBSC7Cord blood5Total35AutologousMarrowBoth marrow & PBSC 34PBSC—Cord blood—Total34Total combinedMarrowBoth marrow & PBSC 64PBSC—Cord blood5Total69All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-182419-442145-642865+9Total82Unrelated 0-181119-441845-644265+26Total97Autologous 0-183519-4411845-6415765+104Total414Total 0-187019-4415745-6422765+139Total593Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
No survivorship program information is available. Contact the center for information about post-transplant care.